Abstract:Osteosarcoma is the most common primary malignant bone tumor in children and adolescents. Unfortunately, treatment failures are common due to the metastasis and chemoresistance, but the underlying molecular mechanism remains unclear. Accumulating evidence indicated that the deregulation of DNA-binding protein high-mobility group box 1 (HMGB1) was associated with the development of cancer. This study aimed to explore the expression of HMGB1 in osteosarcoma tissues and its correlation to the clinical pathology of osteosarcoma and to discuss the role of HMGB1 in the development of osteosarcoma. The results from RT-PCR and Western blot showed that the expression rate of HMGB1 messenger RNA (mRNA) and the expression of HMGB1 in the osteosarcoma tissues were significantly higher than those in normal bone tissue (p<0.05), the expression rate of HMGB1 mRNA and the expression of HMGB1 in the carcinoma tissues with positive lung metastasis were significantly higher than those without lung metastasis (p<0.05), and with increasing Enneking stage, the expression rate of HMGB1 mRNA and the expression of HMGB1 also increased (p<0.05). In order to explore the role of HMGB1 in osteosarcoma, the expression of HMGB1 in the human osteosarcoma MG-63 cell line was downregulated by the technique of RNA interference. Western blot results showed that the protein expression of HMGB1 was significantly decreased in the MG-63 cells from HMGB1-siRNA transfection group (p<0.05), which suggested that HMGB1 was successfully downregulated in the MG-63 cells. Then the changes in proliferation, apoptosis, and invasion of MG-63 cells were examined by MTT test, PI staining, annexin V staining, and transwell chamber assay. Results showed that the abilities of proliferation and invasion were suppressed in HMGB1 knockdown MG-63 cells, and the abilities of apoptosis were enhanced in HMGB1 knockdown MG-63 cells. The expression of cyclin D1, MMP-9 was downregulated in HMGB1 knockdown MG-63 cells, and the expression of caspase-3 was upregulated in HMGB1 knockdown MG-63 cells. Taken together, the overexpression of HMGB1 in osteosarcoma might be related to the tumorigenesis, invasion, and metastasis of osteosarcoma, which might be a potential target for the treatment of osteosarcoma.

Hsa-let-7g Promotes Osteosarcoma by Reducing HOXB1 to Activate NF-kB Pathway.

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Let-7g Reverses Malignant Phenotype of Osteosarcoma Cells by Targeting Aurora-B.

Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.

The MicroRNA Hsa-Let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1

MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis

[miRNA-181a-5p inhibits proliferation and migration of osteosarcoma cell line HOS by targeting HOXB4].

MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion

MicroRNA-187 Suppresses the Proliferation Migration and Invasion of Human Osteosarcoma Cells by Targeting MAPK7.

Overexpression of Mir-664 is Associated with Enhanced Osteosarcoma Cell Migration and Invasion Ability Via Targeting SOX7

Downregulation of miR-19a inhibits the proliferation and promotes the apoptosis of osteosarcoma cells by regulating the JAK2/STAT3 pathway.

Overexpression of Microrna-495 Suppresses the Proliferation and Invasion and Induces the Apoptosis of Osteosarcoma Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.

Mir-181D-5p-foxp1 Feedback Loop Modulates the Progression of Osteosarcoma.

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor

HMGB1 Promotes Cellular Proliferation and Invasion, Suppresses Cellular Apoptosis in Osteosarcoma

miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2

MicroRNA-17 Promotes Osteosarcoma Cells Proliferation and Migration and Inhibits Apoptosis by Regulating SASH1 Expression.

MicroRNA-145 Downregulation Associates with Advanced Tumor Progression and Poor Prognosis in Patients Suffering Osteosarcoma

miR-652 Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HOXA9 and Regulating the PI3K/Akt Signaling Pathway